François Audenet

Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma

François Audenet, Sumit Isharwal, Mark T.A. Donoghue et al. · Clinical Cancer Research · 2018 · 283 citations · Full text

Medicine, Genetics, Oncology +13

Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy

Eugene J. Pietzak, Emily C. Zabor, Aditya Bagrodia et al. · European Urology · 2018 · 152 citations · Full text

Medicine, Oncology, Urology +7

Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study

Évanguelos Xylinas, Pierre Colin, François Audenet et al. · World Journal of Urology · 2012 · 98 citations

Medicine, Surgery, Urology +16

A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi‐institutional database analysis: proposal of patient‐specific risk identification tool

François Audenet, Pierre Colin, David Yates et al. · British Journal of Urology · 2012 · 87 citations · Full text

Medicine, Oncology, Urology +13

<i>Escherichia coli</i> –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer

Anne‐Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva et al. · Cancer Discovery · 2022 · 76 citations · Full text

Medicine, Immunology, Oncology +17